AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Pluri Inc.

Regulatory Filings Dec 9, 2025

6990_rns_2025-12-08_9f39c7ca-b3d9-46c8-b214-0d83de6f54d9.pdf

Regulatory Filings

Open in Viewer

Opens in native device viewer

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

OMB APPRO VAL
OMB Number: 3235-0287
Estimated average
burden hours 0.5
0.0

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

Name and Address of Reporting Pe
Manieu Alexandre Weinstein
erson* 2. Issuer Name and Ticker or Trading Symbol Pluri Inc. [ PLUR ] Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director X 10% Owner
(Last) (First) APT 8002, BURGENSTOCK HORESORT, BURGENSTOCK 30 (Middle) OTELS & 3. Date of Earliest Transaction (Month/Day/Year) 12/04/2025 Officer (give title Other (specify below) below)
(Street) OBBURGEN V8 (City) (State) 6363
(Zip)
4. If Amendment, Date of Original Filed (Month/Day/Year) Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person Y Form filed by More than One Reporting Person
Table I – No on-Derivative Securities Ac quire d, Di sposed of , or Be neficial ly Owned
1. Title of Security (Instr. 3) 2. Transaction
Date
(Month/Day/Year)
2A. Deemed
Execution Date,
if any
(Month/Day/Year)
Code (II ransaction lode (Instr. 3, 4 and 5) lode (Instr. 3) 5. Amount of
Securities
Beneficially Owned
Following
Reported
6. Ownership
Form: Direct
(D) or Indirect
(I) (Instr. 4)
7. Nature of Indirect Beneficial Ownership
Code ٧ Amount (A) or
(D)
Price Transaction(s)
(Instr. 3 and 4)
(Instr. 4)
Common Stock 12/04/2025 (1) A 519 (1) A \$0 10,769 D
Common Stock 1,933,415 I Shares
indirectly
held
through
Chutzpah
Holdings
Limited (2)
Common Stock 452,702 I Shares
indirectly
held
through
Plantae
Bioscience
Ltd. (3)
Table e II – Derivativ
(e.g., put
red, Dispo
options, c
Owned
1. Title of
Derivative
Security (Instr.
3)
2.
Conversion
or Exercise
Price of
Derivative
Security
3. Transaction
Date
(Month/Day/Year)
3A. Deemed
Execution Date,
if any
(Month/Day/Year)
4.
Transac
Code (I
8)
5. Nu
of
Derive
Secur
Acqui
(A) or
Dispo
of (D)
(Instr.
ative
rities
ired
osed
)
6. Date Exer
Expiration Da
(Month/Day/
ate of Securi
Underlyir
ig
e Security
8. Price
of
Derivative
Security
(Instr. 5)
9. Number of
Derivative
Securities
Beneficially
Owned
Following
Reported
Transaction(s)
(Instr. 4)
10.
Ownership
Form:
Direct (D)
or Indirect
(I) (Instr.
4)
11. Nature
of Indirect
Beneficial
Ownership
(Instr. 4)
Code v (A) (D) Date
Exercisable
Expiration
Date
Title Amount
or
Number
of
Shares
1. Name and Address of Reporting Person
Manieu Alexandre Weinstein
* 10% Owner
Director
(Last)
RESORT,
BURGENSTOCK 30
(First) (Middle)
APT 8002, BURGENSTOCK HOTELS &
(Street)
OBBURGEN
(City)
V8
(State)
6363
(Zip)
1. Name and Address of Reporting Person
Chutzpah Holdings Ltd
* 10% Owner
(Last)
4TH FLOOR, LIBERATION HOUSE
CASTLE STREET
(First) (Middle)
(Street)
ST. HELIER
Y9 JE1 4HH
(City) (State) (Zip)

Explanation of Responses:

    1. The restricted stock units ("RSUs") were approved for grant by the Board of Directors on December 4, 2025, under the Company's 2019 Equity Compensation Plan. The RSUs vest equally on a monthly basis over three months following the date of grant.
    1. This statement is jointly filed by and on behalf of each of Chutzpah Holdings Limited ("Chutzpah") and Mr. Weinstein. Mr. Weinstein indirectly owns 100% of Chutzpah and may be deemed to beneficially own securities owned by Chutzpah.
    1. Mr. Weinstein indirectly owns 77% of Plantae Bioscience Ltd. ("Plantae") and may be deemed to beneficially own securities owned by Plantae. Neither the filing of this statement nor anything herein shall be deemed an admission that Mr. Weinstein is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the beneficial owner of any securities owned by Plantae. Mr. Weinstein disclaims beneficial ownership of such securities covered by this statement, except to the extent of his pecuniary interest in such securities. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or13(g) of the Act or any other purpose, a member of a group with respect to the issuer or securities of the issuer.

Remarks:

Exhibit Index: Exhibit 99.1 - Joint Filer Information (incorporated by reference to Exhibit 99.1 for Form 3 filed with the Securities and Exchange Commission on February 18, 2025). Exhibit 99.2 - Joint Filing Agreement (incorporated by reference to Exhibit 99.2 for Form 3 filed with the Securities and Exchange Commission on February 18, 2025). Each reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the beneficial owner of any securities covered by this statement. Each reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or13(g) of the Act or any other purpose, a member of a group with respect to the issuer or securities of the issuer.

/s/ Alexandre Weinstein Manieu 12/08/2025
** Signature of Reporting Person Date
/s/ Ana Ventura Authorized Officer For
Beaumont (Directors) Limited Sole Corporate 12/08/2025
Director
** Signature of Reporting Person Date
/s/ Karen Oliver Authorized Officer For
Beaumont (Directors) Limited Sole Corporate 12/08/2025
Director

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Talk to a Data Expert

Have a question? We'll get back to you promptly.